Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report

Case Reports in Ophthalmological Medicine
Emilio CamposMarina Buzzi

Abstract

To report data which happened to be observed in two glaucoma patients treated with Cord Blood Serum (CBS) eye drops. A case report and retrospective data analysis. CBS topical eye drops, characterized in advance for growth factors (GFs) content, were administered for two months with the aim to relieve their subjective symptoms, in two patients who had referred ocular surface discomfort, although in absence of any sign of keratopathy. As patients were also affected by advanced glaucoma at risk of vision loss and under treatment with hypotensive drugs, they had been also monitored over the same period with IOP controls and visual field tests in our unit. During subsequent visits, data from Mean Deviation and Pattern Standard Deviation in the visual fields were retrospectively collected and compared with before and after treatment with CBS, and an amelioration was observed. CBS contains a combination of GFs, which potentially exert a neuroprotective action and elect CBS as an interesting natural source to be delivered in neurodegenerative ocular disorders. The incidentally observed amelioration in these two patients deserves further investigation in this respect.

References

Jan 27, 1999·Progress in Retinal and Eye Research·H A Quigley
May 18, 2000·Archives of Ophthalmology·R M SchiffmanB L Reis
Oct 22, 2008·Survey of Ophthalmology·M MozaffariehJ Flammer
May 26, 2009·American Journal of Ophthalmology·Helen V Danesh-Meyer, Leonard A Levin
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Alessandro LambiaseRita Levi-Montalcini
Aug 10, 2010·Experimental Eye Research·Shanjean LeeIan A Trounce
Jun 3, 2011·Clinical & Experimental Ophthalmology·Sergio Pinar-SueiroElena Vecino
Feb 22, 2012·Ophthalmology·Elma E Chang, Jeffrey L Goldberg
Oct 17, 2012·Current Opinion in Pharmacology·Vicki ChrysostomouJonathan G Crowston
Mar 7, 2014·The Journal of Bone and Joint Surgery. American Volume·Carola CavalloBrunella Grigolo
May 14, 2014·Visual Neuroscience·Silvia BistiBenedetto Falsini
Jan 23, 2016·Molecular Neurobiology·Pratap KarkiEunsook Lee
Mar 5, 2016·Investigative Ophthalmology & Visual Science·Rachel S ChongKeith R Martin
Aug 6, 2016·Life Sciences·Silvia MolinoManuela Verri
Sep 23, 2016·International Journal of Molecular Sciences·Atsuko KimuraTakayuki Harada
Jan 26, 2017·The Cochrane Database of Systematic Reviews·Dayse F Sena, Kristina Lindsley
Apr 27, 2017·Expert Opinion on Biological Therapy·Svitlana Garbuzova-DavisPaul R Sanberg
Jul 6, 2017·Current Neuropharmacology·Vincenzo ParisiGianluca Manni
Jul 22, 2017·Frontiers in Aging Neuroscience·Ana I RamirezJosé M Ramírez

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
cesarean section
Protein Array

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Arquivos brasileiros de oftalmologia
Vital Paulino CostaRenato Ambrósio
Expert Opinion on Emerging Drugs
Alessandro BagnisCarlo E Traverso
Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria
A Jover BotellaJ Selva Otaolaurruchi
© 2022 Meta ULC. All rights reserved